REPL
Replimune Group, Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$7.00
$-0.38
(-5.15%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $578.01M | EPS (ttm) | $-3.44 | Current Price | $7.00 |
| Enterprise Value | $331.59M | Forward EPS | $-1.99 | Previous Close | $7.38 |
| P/E Ratio | - | ROA | -44.83% | 52W High | $14.79 |
| Forward P/E | -3.51 | ROE | -96.24% | 52W Low | $2.68 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $8.95 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $7.86 |
| P/B Ratio | 1.30 | Profit Margin | - | Volume | 1.90M |
| EV/EBITDA | -1.06 | Current Ratio | 6.31 | Avg Volume | 1.61M |
| EV/Sales | - | Quick Ratio | 6.15 | Beta | 0.75 |
| Employees | 479.00 | Debt/Equity | 28.98 | Shares Outstanding | 82.57M |
| Sector | Healthcare | Total Debt | $76.32M | Float Shares | 52.85M |
| Industry | Biotechnology | Total Cash | $323.64M | Short Float | 34.32% |
| Optionable | Yes | Cash/Share | $4.13 | Short Ratio | 11.52 |
| Dividend Yield | - | Book Value/Share | $5.39 | % Held by Insiders | 2.33% |
| Target Price | $12.71 | Revenue (TTM) | - | % Held by Institutions | 106.51% |